University of California San Francisco Department of Psychiatry
San Francisco, California, 94143, United States
NCT Number: NCT03553992
The 2-year research plan will test the Extended Put It Out Project (POP-6) in a pilot randomized trial (N=168) compared to TSP-6, as well as comparing POP-6 and TSP-6 to the POP-3 and TSP-3 interventions from a previously-conducted trial. Participants will be young adults who smoke, identify as sexual or gender minorities (SGM), and use Facebook. Primary outcome will be biochemically verified 7-day abstinence from smoking at 3 and 6 months. Secondary outcomes will be a quit attempt (y/n), stage of change, and thoughts about tobacco abstinence at 3 and 6 months.
Looking for future studies?
Notify Me18 year–25 year
All sexes
Interventional
Not applicable
San Francisco, California, 94143, United States
Participants will be randomized to one of two conditions: (1) a 6-month Facebook-delivered intervention addressing tobacco use, tailored to SGM young adults; or (2) a 6-month Facebook intervention targeting tobacco use. Both interventions will include 180 days of Facebook-based messages and activities tailored to participants' readiness to quit smoking.
Assessments will occur at baseline, 3, and 6 months follow-up. Assessments will include measures on smoking, thoughts about abstinence, and SGM identity experiences. All participants who report no past 7-day smoking will be asked to give biochemical verification of smoking status with saliva nicotine test kits that will be mailed to participants.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
90 days of Facebook messaging, weekly live sessions targeting tobacco use and tailored to SGM young adults
Drug: nicotine patch 14-day supply of nicotine patch
90 days of Facebook messaging, weekly live sessions targeting tobacco use
Drug: nicotine patch 14-day supply of nicotine patch
Time frame: 3 months post baseline
Reports of no smoking in the 7 days prior to the 3 month assessment. Biochemical verification of abstinence will also be recorded.
Time frame: 6 months post baseline
Reports of no smoking in the 7 days prior to the 6 month assessment. Biochemical verification of abstinence will also be recorded.
Time frame: 3 and 6 months post baseline
Reduction will be assessed at 3 and 6 month follow-ups
Time frame: 3 and 6 months post baseline
A Smoking Questionnaire will assess the presence and number of 24 hr quit attempts since the last assessment, used to calculate presence of at least one quit attempt (y/n) in the assessment time period. This questionnaire has good internal consistency and construct validity, and is routinely used in smoking treatment research.
Time frame: 3 and 6 months post baseline
Proportion of participants ready to quit smoking in the next month assessed at 3 and 6 months.
Time frame: 3 and 6 months post baseline
The 4-item Thoughts About Abstinence Form, will measure thoughts about abstinence (desire to quit, abstinence self-efficacy, and perceived difficulty of quitting) on a scale from 1 ("least") to 10("most"), and abstinence goal as no goal, intermediary goal (e.g., reduced smoking), or total abstinence.
University of California, San Francisco
Other
Acronym: POP-6
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03259360
Behavior, Chemically-Induced Disorders
San Francisco, California, United States
View Trial DetailsNCT03194958
Behavior, Behavior, Addictive
St Louis, Missouri, United States
View Trial DetailsNCT03645941
Behavior, Cigarette Smoking
Rochester, Minnesota, United States
View Trial DetailsNCT03238456
Behavior, Cigarette Smoking
Claremont, California, United States
View Trial Details